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Edited by Irmgard SinningAbstract Human Jagged-1 is predicted to contain 16 epidermal
growth factor-like (EGF) repeats. The oxidative folding of EGF-
2, despite the several conditions tested, systematically led to
complex mixtures. A longer peptide spanning the C-terminal
part of EGF-1 and the complete EGF-2 repeat, on the contrary,
could be readily refolded. This peptide, which corresponds to
the entire exon 6 of the Jagged-1 gene, thus represents an
autonomously folding unit. We show that it is structured in
solution, as suggested by circular dichroism and NMR spectros-
copy, and displays an EGF-like disulﬁde bond topology, as
determined by disulﬁde mapping.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Jagged-1 (SwissProt: JAG1_HUMAN) is one of the ligands
of Notch receptors. Binding of Jagged-1 to Notch receptors
triggers a cascade of proteolytic cleavages [1] that eventually
leads to the release of the intracellular part of the receptor
from the membrane, its translocation to the nucleus, and the
activation of transcription factors [2,3]. These signaling events
play a key role in cell diﬀerentiation and morphogenesis [4],as
proved by the association of malfunctions in the NOTCH
signaling network with several genetically inherited diseases [5]
and with some forms of cancer [6]. Several mutations in the
Jagged-1 gene have been linked with Alagille syndrome [7],
whereas a mutation located in exon 6 of Jagged-1 has been
correlated with familial tetralogy of Fallot [8], a congenital
heart malformation. Jagged-1 is a type I, membrane anchored,
multi-domain protein. The extra-cellular part of Jagged-1 is
predicted to be made of a DSL domain, followed by a series of
16 epidermal growth factor-like (EGF) repeats and a von
Willebrand factor type C (VWC) domain [9]. While for most* Corresponding author. Fax: +39-040-226555.
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Abbreviations: CD, circular dichroism; DSS, 2,2-dimethyl-2-silapen-
tane-5-sulfonate sodium salt; GSH/GSSH, reduced/oxidized gluta-
thione; Fmoc, 9-ﬂuorenylmethoxycarbonyl; LC–MS, liquid
chromatography coupled with mass spectrometry; NMR, nuclear
magnetic resonance; RP-HPLC, reverse phase high performance liquid
chromatography; TCEP, Tris(2-carboxyethyl)phosphine; TFA, triﬂu-
oroacetic acid
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mains and exons, this is not the case of EGF-2. In this report,
we show that exon 6 of Jagged-1 encodes an autonomously
folding unit encompassing the C-terminal part of EGF-1 and
the entire EGF-2 repeat. We assigned the topology of disulﬁde
bonds, and show that the refolded peptide, J1ex6, is struc-
tured, as determined by circular dichroism (CD) and nuclear
magnetic resonance (NMR).2. Materials and methods
2.1. Peptide synthesis
The 33 amino acid peptide corresponding to residues 263–295 of
human Jagged-1 (Swiss-Prot: JAG1_HUMAN), egf-2, and the 44
amino acid peptide corresponding to exon 6 of Jagged-1 (residues 252–
295), J1ex6 (Fig. 1), were synthesized on solid phase (Fmoc/t-Bu
chemistry). The synthesis was automatically performed with a PS3
Protein Technology synthesizer on a 0.05 mmol scale. Cysteines were
manually added as N-a-Fmoc-S-trityl-L-cysteine pentaﬂuorophenyl
ester in order to avoid cysteine racemization [10]. After cleavage from
the resin, the peptides were precipitated with diethylether, washed and
freeze-dried. The reduced peptides were puriﬁed by RP-HPLC on a
Zorbax 300SB-C18 column (Agilent).
2.2. Oxidative folding
Fractions from RP-HPLC were immediately diluted 10 times in the
degassed refolding buﬀer (0.25 M TRIS–HCl, 2 mM EDTA, and GSH/
GSSH 1:1 (w/w), pH 8) and refolded for 18 h. The folding reaction was
monitored by acid quenching of reaction mixture aliquots with TFA
and LC–MS analysis on an API 150 EX single quadrupole mass
spectrometer (Applied Biosystems). J1ex6 was puriﬁed by RP-HPLC
on a Zorbax 300SB-C18 column and freeze-dried.
2.3. CD spectroscopy
Samples for CD spectroscopy were prepared by dissolving the ly-
ophilized peptide in water and adjusting the pH to 6. Peptide con-
centration (35 lM) was determined by UV adsorbance at 280 nm using
calculated e values of 20 110 and 19 630 M1 cm1 for the oxidized and
reduced forms, respectively. Reduction of disulﬁde bonds was achieved
by adding TCEP (1 M) to give a ﬁnal concentration of 4 mM. CD
spectra were recorded on a Jasco J-810 spectropolarimeter in the range
190–250 nm and 250–350 nm using 0.1 · 1 cm quartz cuvettes, re-
spectively. For each spectrum, ﬁve scans were acquired at 10 nm
min1, and the mean residue ellipticity (MRE, deg cm2 dmol1 resi-
due1) was calculated from the baseline-corrected spectrum. A quan-
titative estimation of secondary structure content was carried out using
SELCON3, CONTINLL, CDSSTR, and K2D, all run from the
DichroWeb server [11].
2.4. NMR spectroscopy
Samples for NMR spectroscopy were prepared by dissolving the
lyophilized material in H2O/D2O (90/10, v/v) for a ﬁnal sample con-
centration of 0.5 mM and adjusting the pH to 4.5 with 0.1 N
NaOH. Spectra were recorded on a Bruker Avance DRX 800 oper-
ating at a 1H frequency of 800.13 MHz and equipped with a tripleblished by Elsevier B.V. All rights reserved.
Fig. 1. Amino acid sequence (region of interest) of Jagged-1. Exons are alternatively shown in white and black over a gray background (upper line),
EGF repeats are highlighted in gray (lower line); cysteines are underlined. The egf-2 and the J1ex6 peptides are also shown.
C. Guarnaccia et al. / FEBS Letters 574 (2004) 156–160 157resonance, z-axis gradient cryo-probe. Solvent signal suppression was
achieved using a WATERGATE pulse scheme [12]. 2D NOESY was
recorded using a 150 ms mixing time. Data were transformed using X-
WinNMR (Bruker). Chemical shifts were referenced to DSS.
2.5. Disulﬁde mapping
All proteolysis reactions were carried out at 37 C for 18–48 h in
sodium acetate buﬀer (50 mM, pH 5.2 or pH 6.0) containing 5 mM
CaCl2, and fragments fractionated and analyzed by LC–MS. In the
ﬁrst reaction, the puriﬁed J1ex6 peptide (60 lg) was dissolved in 90 ll
of buﬀer and trypsin (3 lg) was added. After completion, the reaction
mixture was further incubated for 48 h at 37 C in the presence of
thermolysin (6 lg). Fragments were isolated by RP-HPLC and
subjected to a further proteolysis in the presence of proteinase K (1/30,
w/w) for 48 h. Digestion of the intact J1ex6 with proteinase K was
carried out in the same conditions.3. Results and discussion
3.1. Synthesis and oxidative folding
The peptide corresponding to the second EGF repeat of
Jagged-1 (egf-2, residues 263–295, Fig. 1) was prepared by
solid phase chemical synthesis. The peptide was puriﬁed by
RP-HPLC and refolded in the presence of a redox couple, the
oxidative folding reaction being monitored by acid trapping
followed by LC–MS. We tested diﬀerent redox couples (GSH/
GSSH, cysteine/cystine) at diﬀerent molar ratios (1:1 to 10:1),
diﬀerent pH values (sodium borate, pH 9; ammonium acetate,
pH 7–8; TRIS buﬀers in the pH range 7.0–8.5) in the presence
or absence of calcium ions, but we always obtained a complex
mixture of three-disulﬁde species (Fig. 2A). From the analysis
of the Jagged-1 gene structure, we remarked that exon 6, which
is encoding EGF-2, is actually encoding also the C-terminal
region of the preceding putative EGF (Fig. 1). We thus ex-
tended the peptide synthesis to residue 252, comprising part of
the EGF-1 repeat. The corresponding peptide (residues 252–
295, J1ex6) was puriﬁed and refolded in the presence of GSH/
GSSH as redox couple, pH 7.5, to readily yield a single
product (Fig. 2B), which was puriﬁed to homogeneity by RP-
HPLC. J1ex6, therefore, corresponds to the product of exon 6
of the Jagged-1 gene and behaves as an autonomously folding
unit.Fig. 2. Oxidative folding. RP-HPLC (UV detection at 214 nm) of the
folding mixture for egf-2 (A) and J1ex6 (B) after 18 h refolding. Re-
folding conditions were identical: GSH/GSSH (1/1, mol/mol), TRIS
buﬀer (0.25 M, pH 8.0), EDTA (2 mM); solvent A: 0.1% TFA in water
(—); solvent B: 0.1% TFA in acetonitrile (- - -).3.2. CD and NMR spectroscopy
To verify if the refolded, puriﬁed J1ex6 is structured in
solution, CD and NMR spectra were recorded. The CD
spectrum in the far-UV region (Fig. 3A) suggests the presence
of both a and b elements. The positive band at 222 nm
corresponds to a pronounced shoulder in the UV spectrumand can be tentatively assigned to tryptophans transitions
[13], whereas the negative band at 234 nm is often observed
in small disulﬁde-rich polypeptides, where it can be either
positive or negative [14]. The spectrum changes drastically
upon reduction of disulﬁde bonds by TCEP, and shows the
typical features normally displayed by denatured proteins,
like the negative band slightly below 200 nm and the broad
negative band around 220 nm (Fig. 3A). Evident changes can
also be observed in the near-UV CD spectrum (Fig. 3B). The
broad shoulder around 280 nm, which displays the ﬁne
structure typical of tryptophans transitions, is reduced in
intensity and the CD activity around 260 nm corresponding
to disulﬁde bond transitions is close to zero. A quantitative
estimation of secondary structure [11] did not yield satisfac-
tory results. However, this is not surprising. Determination of
secondary structure from CD spectra in small disulﬁde-rich
Fig. 4. NMR spectroscopy. 1H NMR of J1ex6 in H2O/D2O (90/10
v/v). (A) Aromatics/backbone amide region; (B) methyl groups
region.
Fig. 3. CD spectroscopy. CD spectra in the far-UV (A) and near-UV
(B) of oxidized (—) and reduced (  ) J1ex6.
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residues to the CD spectrum in the far-UV region [13,15].
This is especially the case of J1ex6, which has an unusually
high content in aromatic residues (three Trp and two Tyr).
Overall, CD suggests that J1ex6 is structured, as further ev-
idenced by the diﬀerence between the CD of the oxidized and
reduced forms.
These results were conﬁrmed by 1H NMR. A signiﬁcant
dispersion in the backbone NH chemical shifts can be observed
in 1D spectra recorded in H2O (Fig. 4A), as well as an unusual
upﬁeld shift in the resonances of some methyl groups (Fig. 4B),
which can be ascribed to ring current eﬀects arising from ar-
omatic residues. The presence of several NOEs between aro-
matic side chains and methyl groups is a further evidence of
structural compactness (data not shown). Because calcium ions
are known to bind a subset of EGF domains [16], we recorded
1D NMR spectra also in the presence of 20 mM Ca2þ but
could not observe any diﬀerence in the 1D spectrum (data not
shown). Although binding of calcium cannot be ruled out atthis point, calcium ions do not seem to be required for the
structural integrity of J1ex6, nor do they induce any confor-
mational change in J1ex6.
3.3. Disulﬁde mapping
To establish if exon 6 encodes a novel cysteine-rich domain
or rather an unusual EGF-like repeat, the topology of disulﬁde
bonds was determined through a series of sequential proteol-
ysis reactions tailored on the amino acid sequence of J1ex6.
Starting from the hypothesis of an EGF-like disulﬁde topol-
ogy, the ﬁrst reaction was carried out using trypsin, which
cleaved J1ex6 in two fragments, 1–13 and 14–44 (Table 1). The
ﬁrst disulﬁde was then assigned as C2–C11. From the therm-
olysin digestion, three diﬀerent fragments corresponding to the
central region of J1ex6 could be identiﬁed. From the results of
this proteolysis, it was possible to rule out a bead-like ar-
rangement of the two central disulﬁde bonds. At the same
time, the last disulﬁde was tentatively assigned as C33–C42.
This assignment was independently conﬁrmed by the proteol-
ysis of the intact J1ex6 with proteinase K. In order to distin-
guish between the two possibilities for the central disulﬁdes
(C14–C25, C20–C31 or C14–C31, C20–C25), the fragment
14–20/24–31 was puriﬁed by RP-HPLC and digested with
proteinase K. The central region of J1ex6 turned out to be very
resistant to proteolysis despite the broad speciﬁcity of pro-
teinase K. The identiﬁed fragments 14/24–29 and 15–20/30–31,
however, were suﬃcient to assign the central disulﬁdes as C14–
C25 and C20–C31 (Table 1). J1ex6 has therefore the disulﬁde
Table 1
Disulﬁde mapping
Enzyme Fragment Sequence number Mass (calc.) Mass (found) Disulﬁdes
Trypsin RCQYGWQGLYCDK 1–13 1617.8 1617.7 2–11
1618.3 (+1)
809.5 (+2)
CIPHPGCVHGICNEPWQCLCET-
NWGGQLCDK
14–44 3435.9 3435.91
1719.0 (+2)
1146.0 (+3)
–
Thermolysina CIPHPGCVHGICNEPWQC 14–31 1989.3 1988.8 14–25, 20–31
995.3 (+2) or
664.0 (+3) 14–31, 20–25
CIPHPGC/ICNEPWQCb 14–20/24–31 1714.0 1714.4
1715.5 (+1)
858.3 (+2)
572.5 (+3)
C/IPHPGC/ICNEPWQC 14/15–20/24–31 1732.0 1731.8
1732.3 (+1)
866.8 (+2)
578.3 (+3)
Proteinase K LCETNWGGQLCDK 32–44 1464.6 1465.0 33–42
1466.0 (+1)
733.5 (+2)
C/ICNEPWc 14/24–29 880.0 879.6 14–25
880.5 (+1)
440.8 (+2)
IPHPGC/QCc 15–20/30–31 870.0 869.8 20–31
870.5 (+1)
436.0 (+2)
Proteolytic enzyme, sequence (cysteines in bold) and residue number of the fragments identiﬁed by LC–MS, calculated mass (Da) of the fragment,
experimental mass (Da) of the fragment obtained by deconvolution of the observed multiple charge spectra, and disulﬁde bond assignments; (a) the
thermolysin digestion was carried out in one pot after completion of the trypsin digestion; the fragment (b) was puriﬁed by RP-HPLC and subjected
to proteinase K digestion, to yield fragments (c). See Section 2 for experimental details. In fragments made of two or more peptide chains joined by
disulﬁde bonds, diﬀerent chains are separated by a slash (/).
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disulﬁde bond in its N-terminal extension.
In conclusion, while rather unexpectedly we were not able to
refold EGF-2 despite the variety of conditions used, J1ex6,
which corresponds to the entire exon 6, behaves as an auton-
omously folding unit and is structured in solution.
In Jagged–1, 17 exons encode 16 putative EGF repeats. Of
these, 14 are predicted with a relatively high conﬁdence (E-
values between 1.9  102 and 2.4  1012) [9]. On the con-
trary, EGF-1 and )2 are predicted with anE-value of 16 and 24,
respectively. A univocal correspondence between EGF repeats
and exons occurs in 12 out of 16 cases, but not for EGF-2.
EGF-2 is encoded by exon 6, which also encodes the C-terminal
part of EGF-1 (Fig. 1). In our hands, this part turned out to be
required for the folding of EGF-2 to occur and the correct di-
sulﬁde bonds to be formed. In other words, the C-terminal part
of EGF-1 seems to work as an intra-molecular chaperone in the
folding of EGF-2. A similar eﬀect was observed in the folding of
bovine pancreatic trypsin inhibitor, where a short, 13 residue
pro-region containing a single cysteine facilitates the oxidative
folding of this small, three-disulﬁde protein [17]. A role for pro-
domains and pro-sequences in assisting folding of a number of
proteins has been described [18,19].
In 1978, Blake had already proposed that exonic regions of
DNA correspond to ‘‘folded protein units’’ [20]. The debate
on the introns-early and introns-late theory on the origin of
genes [21] later drifted towards the correspondence between
exons and units of protein structure. This correspondence was
strongly criticized by Doolittle [22] and recent evidence sug-
gests that at least for ancient proteins, only the position ofphase zero introns is correlated with boundaries of domains,
deﬁned as compact structural units by geometrical means [23].
Introns of phase 1 and 2 might have been added later and are
not related to structural features [23]. In the case reported
here, (i) the predicted sequence domain boundaries do not
seem to coincide with the boundaries of the autonomously
folding unit and (ii) this apparent folding unit is limited by
non-zero phase introns (phase 2 and phase 1). Although
general conclusions cannot be drawn at this stage, it is
tempting to speculate that while exons encode autonomously
folding units, or folding domains, as originally suggested [20],
in some instances these might not necessarily coincide with
structural domains. Because protein folding in the living cell
is a process that has to be both highly productive and re-
producible, evolutionary pressure might have operated at the
exon/intron organization level of eukaryotic genes not only to
select for optimized function but also in order to arrange
multi-domain proteins in optimized folding units. Indeed,
selection based on function optimization can work only on
‘‘foldable’’ proteins [20]. Interestingly, the average length of a
typical EGF repeat (35–40 amino acids) is very close to the
most probable value of the exon length found in eukaryotic
genes [24]. This might have also been the length of early
folding units [25]. The annotation of several eukaryotic ge-
nomes, together with the steadily increasing number of pro-
tein structures available, is leading to the development of
dedicated tools for the study of exon position within three-
dimensional structures [26]. Although the relationship be-
tween exons and folding units has been addressed [27], more
data on the folding, rather than on the structure, of individual
160 C. Guarnaccia et al. / FEBS Letters 574 (2004) 156–160exon-encoded polypeptides should provide insights into this
possible association.
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